| Literature DB >> 31186336 |
Calum A Pattrick1, Joseph P Webb1, Jeffrey Green1, Roy R Chaudhuri1, Mark O Collins2,3, David J Kelly4.
Abstract
Vanillin (4-hydroxy-3-methoxybenzaldehyde) is an economically important flavor compound that can be made in bacterial cell factories, but toxicity is a major problem for cells producing this aromatic aldehyde. Using (i) a global proteomic analysis supported by multiple physiological experiments, mutant analyses, and inferred transcription factor modeling and (ii) adaptive laboratory evolution (ALE) of vanillin tolerance combined with genome-wide analysis of the underlying mutations, mechanisms of vanillin toxicity in Escherichia coli have been elucidated. We identified 147 proteins that exhibited a significant change in abundance in response to vanillin, giving the first detailed insight into the cellular response to this aldehyde. Vanillin caused accumulation of reactive oxygen species invoking adaptations coordinated by a MarA, OxyR, and SoxS regulatory network and increased RpoS/DksA-dependent gene expression. Differential fumarase C upregulation was found to prevent oxidative damage to FumA and FumB during growth with vanillin. Surprisingly, vanillin-dependent reduction pf copper (II) to copper (I) led to upregulation of the copA gene and growth in the presence of vanillin was shown to be hypersensitive to inhibition by copper ions. AcrD and AaeAB were identified as potential vanillin efflux systems. Vanillin-tolerant strains isolated by ALE had distinct nonsynonymous single nucleotide polymorphisms (SNPs) in gltA that led to increased citrate synthase activity. Strain-specific mutations in cpdA, rob, and marC were also present. One strain had a large (∼10-kb) deletion that included the marRAB region. Our data provide new understanding of bacterial vanillin toxicity and identify novel gene targets for future engineering of vanillin-tolerant strains of E. coli IMPORTANCE A particular problem for the biotechnological production of many of the valuable chemicals that we are now able to manufacture in bacterial cells is that these products often poison the cells producing them. Solutions to improve product yields or alleviate such toxicity using the techniques of modern molecular biology first require a detailed understanding of the mechanisms of product toxicity. Here we have studied the economically important flavor compound vanillin, an aromatic aldehyde that exerts significant toxic effects on bacterial cells. We used high-resolution protein abundance analysis as a starting point to determine which proteins are upregulated and which are downregulated by growth with vanillin, followed by gene expression and mutant studies to understand the mechanism of the response. In a second approach, we evolved bacterial strains with higher vanillin tolerance. Their genome sequences have yielded novel insights into vanillin tolerance that are complementary to the proteomics data set.Entities:
Keywords: adaptive evolution; aldehyde; citrate synthase; copper; proteomics; stress responses
Year: 2019 PMID: 31186336 PMCID: PMC6561319 DOI: 10.1128/mSystems.00163-19
Source DB: PubMed Journal: mSystems ISSN: 2379-5077 Impact factor: 6.496
FIG 1Summary of proteome changes in E. coli BW25113 in response to vanillin. (A) Cells from four independent replicate cultures grown without or with 10 mM vanillin were harvested for proteomic analysis at the same cell density (OD600 of 0.5) represented by the red dotted line in the growth curves shown. (B) Histogram of numbers of upregulated (green) and downregulated (red) proteins during growth with vanillin identified by LC-MS/MS, classified according to COG/NCBI functional categories. Five proteins that were upregulated, NfnB, HdhA, YghA, YbjP, and YbgI, do not have an assigned COG; one protein that was downregulated, YjjL, is also unassigned. (C) Volcano plot of the P values versus the log2 t test differences between the cultures grown without or with 10 mM vanillin. From the total data set of proteins identified, 147 proteins were significantly changed in abundance; the results of t tests of the quantitative data are shown here. Proteins indicated above the gray lines showed a significant change in abundance during growth with vanillin. A selection of proteins belonging to the Fnr regulon (red), the SoxS regulon (blue), and the OxyR regulon (orange) is shown. A selection of additional proteins of interest (black) is shown. Full lists of proteins showing significant changes are given in Tables 1 and 2.
Proteins quantified by label-free proteomic analysis that showed a significant increase in abundance in response to vanillin treatment
| Protein | Protein description | Fold increase | |
|---|---|---|---|
| Oxidative stress defense | |||
| AhpC | Alkyl hydroperoxide reductase subunit C | 4.1 | 1.86E−05 |
| AhpF | Alkyl hydroperoxide reductase subunit F | 2.6 | 1.30E−04 |
| KatE | Catalase HPII | 4.8 | 4.65E−02 |
| MarR | Multiple antibiotic resistance protein | 9.4 | 3.89E−03 |
| OsmC | Peroxiredoxin | 4.4 | 2.74E−03 |
| SodA | Superoxide dismutase (Mn) | 5.0 | 3.58E−02 |
| Glutathione | |||
| GrxB | Glutaredoxin-2 | 7.5 | 4.94E−04 |
| GshB | Glutathione synthetase | 8.4 | 1.44E−02 |
| Gss | Glutathionylspermidine synthetase/amidase | 3.4 | 5.99E−04 |
| GstA | Glutathione | 4.2 | 1.14E−02 |
| YghU | Disulfide-bond oxidoreductase | 6.5 | 1.01E−03 |
| YqjG | Glutathionyl-hydroquinone reductase | 3.7 | 5.01E−04 |
| Low-MW compound accumulation | |||
| GadC | Glutamate/γ-aminobutyrate antiporter | 5.5 | 4.87E−03 |
| GltB | Glutamate synthase (NADPH) large chain | 2.8 | 9.58E−02 |
| OtsA | α,α-Trehalose-phosphate synthase (UDP forming) | 4.6 | 1.48E−03 |
| Chaperones and proteases | |||
| CbpA | Curved DNA-binding protein | 3.4 | 3.89E−03 |
| ClpB | Chaperone protein | 2.8 | 3.78E−05 |
| Dcp | Periplasmic serine endoprotease | 3.1 | 1.44E−05 |
| DegP | Periplasmic serine endoprotease | 5.7 | 1.08E−05 |
| HchA | Molecular chaperone Hsp31 and glyoxalase 3 | 9.6 | 2.72E−03 |
| HslO | 33-kDa chaperonin | 4.3 | 2.23E−02 |
| PepB | Peptidase B | 5.2 | 2.45E−05 |
| Metal homeostasis | |||
| EntB | Enterobactin synthase component B | 37.2 | 1.17E−05 |
| EntE | Enterobactin synthase component E | 8.5 | 1.19E−03 |
| EntF | Enterobactin synthase component F | 23.1 | 6.64E−03 |
| MoaB | Molybdenum cofactor biosynthesis protein B | 9.2 | 1.40E−06 |
| SufB | FeS cluster assembly protein | 5.9 | 4.04E−04 |
| SufD | FeS cluster assembly protein | 5.2 | 6.42E−03 |
| SufS | Cysteine desulfurase | 5.6 | 1.86E−03 |
| Aldehyde detoxification | |||
| Ahr | Aldehyde reductase | 8.5 | 1.82E−03 |
| AldB | Aldehyde dehydrogenase B | 7.9 | 6.58E−04 |
| DkgA | 2,5-Diketo- | 41.1 | 6.46E−04 |
| YahK | Aldehyde reductase | 3.6 | 3.90E−02 |
| YghA | Uncharacterized oxidoreductase | 4.3 | 1.87E−02 |
| YqhD | Alcohol dehydrogenase | 34.8 | 6.11E−04 |
| Central carbon metabolism and energy production | |||
| AceA | Isocitrate lyase | 5.1 | 3.15E−02 |
| AceB | Malate synthase A | 6.4 | 6.52E−03 |
| AcnA | Aconitate hydratase 1 | 8.0 | 7.53E−03 |
| Acs | Acetyl-coenzyme A synthetase | 5.6 | 2.60E−02 |
| FbaB | Fructose-bisphosphate aldolase class 1 | 6.9 | 2.82E−03 |
| FumC | Fumarate hydratase class II | 38.4 | 1.49E−05 |
| GltA | Citrate synthase | 3.3 | 1.51E−02 |
| Mdh | Malate dehydrogenase | 4.0 | 3.12E−04 |
| MtlA | PTS mannitol-specific EIICBA component | 4.1 | 4.68E−04 |
| PfkB | ATP-dependent 6-phosphofructokinase isozyme 2 | 3.6 | 2.00E−02 |
| Ppk | Polyphosphate kinase | 3.5 | 6.31E−04 |
| PoxB | Pyruvate oxidase (ubiquinone reducing) | 10.9 | 1.24E−02 |
| Sad | Succinate semialdehyde dehydrogenase | 6.8 | 1.02E−02 |
| TalA | Transaldolase A | 4.7 | 1.06E−02 |
| TktB | Transketolase 2 | 5.3 | 2.03E−02 |
| Zwf | Glucose-6-phosphate 1-dehydrogenase | 3.6 | 4.46E−04 |
| Nitrocompound detoxification | |||
| NfsA | Oxygen-insensitive NADPH nitroreductase | 12.8 | 5.64E−06 |
| NfnB | Oxygen-insensitive NAD(P)H nitroreductase | 14.8 | 7.03E−06 |
| Amino acid biosynthesis | |||
| AstC | Succinylornithine transaminase | 4.1 | 4.80E−02 |
| HisB | Histidine biosynthesis bifunctional protein | 5.5 | 4.59E−03 |
| HisC | Histidinol-phosphate aminotransferase | 5.2 | 2.21E−02 |
| HisD | Histidinol dehydrogenase | 3.8 | 2.90E−03 |
| HisG | ATP phosphoribosyltransferase | 8.0 | 9.55E−05 |
| IlvB | Acetolactate synthase isozyme 1 large subunit | 3.9 | 3.32E−02 |
| LysC | Lysine-sensitive aspartokinase 3 | 3.0 | 4.23E−04 |
| PheA | P-protein | 3.4 | 1.13E−02 |
| TrpB | Tryptophan synthase beta chain | 2.7 | 6.73E−04 |
| YecD | Isochorismatase family protein | 7.2 | 5.35E−04 |
| Folate metabolism | |||
| FolE | GTP cyclohydrolase 1 | 3.1 | 1.31E−04 |
| PanB | 3-Methyl-2-oxobutanoate hydroxymethyltransferase | 3.5 | 8.48E−03 |
| YbgI | Putative GTP cyclohydrolase 1 type 2 | 3.1 | 7.58E−03 |
| YgfZ | tRNA-modifying protein | 4.9 | 2.44E−03 |
| β- | |||
| UidA | Beta-glucuronidase | 5.6 | 1.78E−03 |
| UxaC | Uronate isomerase | 12.8 | 8.36E−05 |
| UxuA | Mannonate dehydratase | 4.1 | 1.00E−02 |
| Uncharacterized | |||
| YbjP | Uncharacterized lipoprotein | 4.0 | 4.46E−02 |
| YdhJ | Uncharacterized protein | 3.5 | 1.06E−02 |
| YeiR | Uncharacterized protein | 6.4 | 1.90E−02 |
| YhbW | Uncharacterized protein | 77.1 | 4.18E−08 |
| YjhC | Uncharacterized oxidoreductase | 23.8 | 4.43E−03 |
| YncE | Uncharacterized protein | 9.5 | 1.31E−02 |
| Others | |||
| Add | Adenosine deaminase | 3.5 | 2.75E−04 |
| Amn | AMP nucleosidase | 5.5 | 6.10E−06 |
| AnmK | Anhydro-N-acetylmuramic acid kinase | 3.2 | 2.39E−04 |
| Cfa | Cyclopropane-fatty-acyl-phospholipid synthase | 4.2 | 4.81E−04 |
| CodA | Cytosine deaminase | 3.2 | 2.99E−02 |
| CurA | NADPH-dependent curcumin reductase | 4.1 | 3.97E−03 |
| DcyD | 4.4 | 3.35E−03 | |
| EmrA | Multidrug export protein | 4.5 | 1.26E−02 |
| GhrA | Glyoxylate/hydroxypyruvate reductase A | 4.8 | 5.56E−04 |
| HdhA | 7-Alpha-hydroxysteroid dehydrogenase | 10.4 | 3.08E−04 |
| HemB | Delta-aminolevulinic acid dehydratase | 9.0 | 3.32E−03 |
| LysU | Lysine-tRNA ligase, heat inducible | 3.8 | 1.18E−05 |
| MdaB | Modulator of drug activity B | 8.4 | 1.93E−05 |
| MetG | Methionine-tRNA ligase | 2.7 | 4.19E−05 |
| MnmA | tRNA-specific 2-thiouridylase | 2.8 | 1.60E−02 |
| TorA | Trimethylamine-N-oxide reductase 1 | 8.1 | 5.48E−03 |
| YadG | Uncharacterized ABC transporter ATP-binding protein | 8.9 | 3.26E−04 |
Fold increase data were calculated from the average abundances of four independent vanillin-treated replicates relative to those of the four independent untreated replicates. PTS, phosphotransferase system.
Proteins quantified by label-free proteomic analysis that showed a significant decrease in abundance in response to vanillin treatment
| Protein | Protein description | Fold | |
|---|---|---|---|
| Anaerobic response and FeS-cluster-containing proteins | |||
| DmsA | Dimethyl sulfoxide reductase | 21.5 | 1.90E−03 |
| FrdA | Fumarate reductase flavoprotein subunit | 4.3 | 9.34E−05 |
| FrdB | Fumarate reductase iron-sulfur subunit | 6.5 | 2.09E−05 |
| FumB | Fumarate hydratase class I, anaerobic | 4.8 | 2.79E−03 |
| GlpA | Anaerobic glycerol-3-phosphate dehydrogenase subunit A | 24.7 | 6.51E−04 |
| GlpB | Anaerobic glycerol-3-phosphate dehydrogenase subunit B | 4.6 | 3.39E−03 |
| MiaB | tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase | 9.1 | 1.56E−02 |
| NarG | Respiratory nitrate reductase 1 alpha chain | 6.2 | 9.52E−02 |
| NarH | Respiratory nitrate reductase 1 beta chain | 11.4 | 1.09E−02 |
| NirB | Nitrite reductase (NADH) large subunit | 37.4 | 2.96E−04 |
| PreT | NAD-dependent dihydropyrimidine dehydrogenase subunit | 15.4 | 1.46E−06 |
| SdaB | 31.1 | 1.13E−01 | |
| TdcG | 12.3 | 3.04E−05 | |
| Glycyl radical proteins | |||
| GrcA | Autonomous glycyl radical cofactor | 5.2 | 1.88E−03 |
| TdcE | PFL-like enzyme (ketobutyrate formate lyase) | 60.6 | 2.89E−04 |
| Maltose and trehalose | |||
| LamB | Maltoporin | 16.5 | 8.15E−03 |
| MalE | Maltose-binding periplasmic protein | 15.0 | 1.34E−03 |
| MalP | Maltodextrin phosphorylase | 4.5 | 3.21E−05 |
| MalQ | 4-Alpha-glucanotransferase | 5.5 | 1.44E−03 |
| TreB | PTS trehalose-specific EIIBC component | 36.2 | 4.38E−03 |
| TreC | Trehalose-6-phosphate hydrolase | 9.5 | 1.53E−04 |
| Porins | |||
| FadL | Long-chain fatty acid transport protein | 10.4 | 7.97E−03 |
| OmpF | Outer membrane protein F | 11.5 | 2.18E−02 |
| Tsx | Nucleoside-specific channel-forming protein | 5.3 | 2.82E−03 |
| Replication and cell division | |||
| DeaD | ATP-dependent RNA helicase | 13.9 | 1.40E−02 |
| MnmG | tRNA uridine 5-carboxymethylaminomethyl modification | 7.6 | 2.89E−02 |
| MurA | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 3.6 | 2.89E−03 |
| ParE | DNA topoisomerase 4 subunit B | 6.1 | 2.10E−02 |
| RimO | Ribosomal protein S12 methylthiotransferase | 3.1 | 1.52E−02 |
| RplD | 50S ribosomal protein L4 | 3.2 | 1.78E−02 |
| RplP | 50S ribosomal protein L16 | 4.3 | 2.28E−02 |
| RplT | 50S ribosomal protein L20 | 3.4 | 2.78E−02 |
| RplU | 50S ribosomal protein L21 | 3.3 | 4.12E−03 |
| RplY | 50S ribosomal protein L25 | 4.0 | 3.47E−02 |
| RpmB | 50S ribosomal protein L28 | 3.2 | 1.86E−02 |
| TtcA | tRNA 2-thiocytidine biosynthesis protein | 8.7 | 2.84E−02 |
| LPS biosynthesis | |||
| rfbB | dTDP-glucose 4,6-dehydratase 1 | 3.8 | 3.06E−05 |
| RfbD | dTDP-4-dehydrorhamnose reductase | 4.3 | 1.17E−02 |
| Aspartate/asparagine catabolism | |||
| AnsB | 7.8 | 1.19E−02 | |
| AsnA | Aspartate-ammonia ligase | 7.1 | 3.30E−03 |
| AspA | Aspartate ammonia-lyase | 5.7 | 1.09E−05 |
| Glyoxylate degradation | |||
| GarD | 3.8 | 3.55E−03 | |
| GarR | 2-Hydroxy-3-oxopropionate reductase | 8.7 | 2.70E−03 |
| Uncharacterized | |||
| YdhQ | Uncharacterized protein YdhQ | 5.5 | 9.51E−04 |
| YgeV | Uncharacterized σ54-dependent transcriptional regulator | 3.4 | 2.01E−03 |
| YjjI | Uncharacterized protein YjjI | 6.2 | 3.36E−03 |
| Others | |||
| FtnA | Bacterial nonheme ferritin | 5.2 | 1.83E−02 |
| GatZ | 4.1 | 2.37E−03 | |
| GuaC | GMP reductase | 4.7 | 1.72E−03 |
| HupA | DNA-binding protein HU-alpha | 4.1 | 4.90E−03 |
| HypB | Hydrogenase isoenzymes nickel incorporation protein | 7.1 | 5.01E−02 |
| NanA | N-Acetylneuraminate lyase | 3.4 | 3.08E−03 |
| PepE | Peptidase E | 3.9 | 5.16E−04 |
| RpoS | RNA polymerase sigma factor | 4.9 | 3.77E−04 |
Fold decrease was calculated from the average abundance of four independent vanillin-treated replicates relative to that of the four independent untreated replicates. LPS, lipopolysaccharide; PFL, pyruvate formate lyase.
FIG 2Inferred changes in transcription factor activities in response to vanillin. The output from the TFInfer program (Asif et al. [32]) in the absence (open bars) and presence (filled bars) of vanillin is shown. The error bars represent standard deviations provided by the posterior distributions. The full output is shown in Table S4.
FIG 3Major regulatory networks mediating changes in protein abundance in response to vanillin. The regulators are shown as named circles colored to indicated increased (red) or decreased (blue) activity in the presence of vanillin. The brightness of the shading is a visual indication of extent of the predicted changes in activities as depicted in Fig. 2; the brighter the color, the greater the response. The regulated proteins (red, increased abundance in the presence of vanillin; blue, decreased abundance) are aligned across the center of the diagram and are linked to the relevant regulators by as indicated by the following symbols: →, activation; –I, inhibition; →|, dual responses.
FIG 4Vanillin detoxification by reduction to vanillyl alcohol. (A) 1H-NMR spectra of supernatants from cells incubated aerobically in LB for 0 h (black trace) or 24 h (red trace) with 10 mM vanillin. Reference spectra of vanillin (purple trace), vanillyl alcohol (green trace), or vanillic acid (light blue trace) are also shown. The dotted lines indicate the resonances of vanillin, which decreased in intensity after 24 h (the slight changes in chemical shift were probably due to pH changes in the culture during the incubation period). Resonances corresponding to the accumulation of vanillyl alcohol after 24 h are indicated (* and [). (B and C) Vanillin-dependent NADPH oxidation by purified recombinant YqhD (B) and DkgA (C). Data represent means and standard deviation of results from triplicate assays. Kinetic parameters are given in the text. (D) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD600) of the BW25113 wild-type parent and single-gene-deletion strains from the Keio collection. Data represent means and standard deviation of results from triplicate cultures. A value of 100% corresponds to an OD600 of 0.49 ± 0.04. ***, P < 0.001; *, P < 0.05 (by one-way analysis of variance [ANOVA] compared to the WT). NS, not significant.
FIG 5Changes in abundances of enzymes of central carbon metabolism during growth with vanillin and differential fumarase regulation. (A) Enzymes catalyzing the reactions shown in green were increased in abundance during growth with vanillin by the fold changes shown; enzymes catalyzing reactions shown in red were decreased by the fold changes shown. Enzymes catalyzing the reactions shown in dark blue showed no significant change in abundance. The thickness of the arrows is proportional to the fold change. PGL, 6-phosphogluconolactone; 6PG, 6-phosphogluconate; Rbu5P, ribulose-5-phosphate; R5P, ribose-5-phosphate; X5P, xylulose-5-phosphate; E4P, erythrose 4-phosphate; F6P, fructose 6-phosphate; S7P, sedoheptulose 7-phosphate; DHAP, dihydroxyacetone phosphate; GA3P, glyceraldehyde 3-phosphate; 1,3BPG, 1,3-bisphosphoglyceric acid; 3PG, 3-phosphoglyceric acid; 2PG, 2-phosphoglyceric acid; PEP, phosphoenolpyruvate. (B) Total fumarase activity of E. coli cell extracts from wild-type and fumarase-deficient cells grown in the absence or presence of 10 mM vanillin was measured spectrophotometrically at 240 nm. The data represent mean levels of activity of extracts from three independent cultures; error bars represent standard deviations. *, P = 0.01 to 0.05; **, P = 0.001 to 0.01; ***, P = <0.001 (by Student's t test). (C) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD600) of BW25113 wild-type parent and single-gene-deletion strains from the Keio collection. Data represent means and standard deviations of results from triplicate cultures. A value of 100% corresponds to an OD600 of 0.49 ± 0.04. NS, not significant (compared to WT). ***, P < 0.001 (by one-way ANOVA compared to the WT).
FIG 9Phenotypic analysis of EVT strains. (A) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD600) of BW25113 wild-type parent and EVT strains 1 to 4. A value of 100% corresponds to an OD600 of 0.49 ± 0.04. (B) Specific activity of citrate synthase (GltA) in wild-type and EVT strain cell extracts (cells were grown in LB without vanillin). (C) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD 600 nm) of BW25113 wild-type parent and a single gene deletion mutant in the rob gene, derived from the Keio collection. A value of 100% corresponds to an OD600 of 0.49 ± 0.04. In panels A to C, the data represent means of results from three independent cultures or assays, with standard deviations shown as error bars. *, P = 0.01 to 0.05; **, P = 0.001 to 0.01; ****, P < 0.0001 (one-way ANOVA [A and B] or Student's t test [C]). (D) The ∼10-kb chromosome deletion in EVT4 and the effect of individual single-gene knockouts in this region on vanillin tolerance. (Upper panel) The 9,699-bp region deleted in EVT4, encompassing genes yneG to eamA with partial deletion of dcgF, as shown by the sequence read density (gray vertical bars). (Lower panel) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD600) of BW25113 wild-type parent and single-gene-deletion strains from the Keio collection. A value of 100% corresponds to an OD600 of 0.49 ± 0.04. Red bars indicate significantly decreased growth (P < 0.05 by one-way ANOVA), and green bars significantly increased growth (P < 0.05 by one-way ANOVA) compared to the wild type. Gray bars indicate no significant change.
FIG 6Vanillin treatment elicits reactive oxygen species (ROS) production and an oxidative stress response in E. coli. (A) Time-dependent increase in endogenous ROS levels in intact cells in response to 0.5 mM vanillin treatment (blue bars) detected by use of the ROS-activated fluorescent dye 2′,7′-dihydrodichlorofluorescein diacetate (H2DCFDA). The control without vanillin (white bars) showed no significant change. [A.U.], arbitrary units. (B) Same experiment as that described in the panel A legend but with 0.5 mM vanillic acid (purple bars) or vanillyl alcohol (red bars) compared to the control with no additions (white bars). Note the different fluorescence scale compared to panel A. (C and D) Experiments were performed in a manner similar to that described in the panel A legend with 0.5 mM vanillin, comparing the wild type (blue solid bars) with isogenic katE (C) or sodA (D) mutants from the Keio collection (green bars). (E) RT-PCR data showing changes in transcript levels of the oxidative stress response transcriptional activators soxS and marA in strains grown with and without 10 mM vanillin. Expression levels are expressed relative to the levels determined for untreated cells and normalized to the rrsA housekeeping gene. Data are plotted as means of results from three biological replicates (each consisting of three technical replicates) with standard deviations shown as error bars. (F) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD600) of the BW25113 wild-type parent and the single-gene-deletion strains indicated (from the Keio collection). A value of 100% corresponds to an OD600 of 0.49 ± 0.04. In all panels, data are plotted as means of results from three biological replicates with standard deviations as error bars. *, P = 0.01 to 0.05; **, P = 0.001 to 0.01; ***, P < 0.001; ****, P < 0.0001 (Student's t test [A to E] or one-way ANOVA [F]).
FIG 7Vanillin-dependent changes in metal homeostasis. (A) Inductively coupled plasma mass spectrometry (ICP-MS) analysis of intracellular metal content of E. coli BW25113 in response to growth with 10 mM vanillin. (B) RT-PCR showing expression of copA in response to 10 mM vanillin relative to expression in untreated cells (control). Expression levels are normalized to the rrsA housekeeping gene. (C) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD600) of BW25113 wild-type parent and isogenic copA deletion strain from the Keio collection. A value of 100% corresponds to an OD600 of 0.49 ± 0.04. (D) Cell density after 24 h growth of E. coli BW25113 in minimal medium alone (dark colored bars) or with 10 mM vanillin (light colored bars). Either no additional metal ions were added (None) or 5 μM copper II sulfate (+ Cu), 200 μM iron (II) sulfate (+ Fe), or 200 μM Mn (II) sulfate (+ Mn) was added. In each panel, the data shown represent means plus standard deviations of results from three independent cultures. *, P = 0.01 to 0.05; **, P = 0.001 to 0.01; ***, P < 0.001; ****, P < 0.0001 (Student's t test).
FIG 8Gene expression and mutant phenotypes for genes encoding potential vanillin efflux systems. In (A and B) RT-PCR shows expression ratios for the genes shown in E. coli BW25113 cells treated with 10 mM vanillin relative to untreated cells, normalized to expression of rrsA. (C) Comparison of levels of growth in LB plus 10 mM vanillin at 6 h after inoculation (OD600) of BW25113 wild-type parent and single-gene-deletion strains from the Keio collection. A value of 100% corresponds to an OD600 of 0.49 ± 0.04. In each panel, the data represent means of results from three independent cultures with standard deviations shown as error bars. **, P = 0.001 to 0.01; ***, P < 0.001; ****, P < 0.0001 (Student's t test [A and B] or one-way ANOVA [C]).
Genomic changes identified in EVT E. coli strains
| Strain | Position (bp) | Change | Gene(s) | Description |
|---|---|---|---|---|
| EVT1 | 749566 | R119L (CGT→CTT) | Citrate synthase | |
| 4625115 | Δ1 bp, coding (12/870 nt) | Right origin-binding protein | ||
| EVT2 | 748772 | A384T (GCA→ACA) | Citrate synthase | |
| 1612766 | Δ11 bp, coding (389–399/666 nt) | Inner membrane protein | ||
| EVT3 | 749516 | G136S (GGT→AGT) | Citrate synthase | |
| 4624518 | Q203stop (CAG→TAG) | Right origin-binding protein | ||
| 3169702 | L162del (CTGCAT→CAT) | cAMP phophodiesterase | ||
| EVT4 | 749443 | A160V (GCC→GTC) | Citrate synthase | |
| 1605879 | Δ9,699 bp | 12 genes | ||
EVT, evolved vanillin tolerant; nt, nucleotide.
Kinetic parameters determined for purified recombinant wild-type and variant citrate synthases with mutations matching those in strains EVT1 to EVT4
| Citrate | ||||
|---|---|---|---|---|
| WT | 154 ± 25 | 4.8 ± 0.3 | 232 ± 14 | 1,506 ± 88 |
| R119L (EVT1) | 45 ± 12 | 5.6 ± 0.4 | 268 ± 18 | 5,955 ± 613 |
| A384T (EVT2) | 62 ± 6 | 4.0 ± 0.1 | 192 ± 7 | 3,096 ± 119 |
| G136S (EVT3) | 37 ± 4 | 4.5 ± 0.1 | 214 ± 7 | 5,783 ± 90 |
| A160V (EVT4) | 42 ± 7 | 4.2 ± 0.2 | 202 ± 10 | 4,809 ± 181 |
The data shown are means and standard deviations of at least three independent rate measurements over a range of oxaloacetate concentrations at a fixed concentration of acetyl-CoA, using the DTNB assay for CoA formation (see Materials and Methods).